Navigation Links
UCLA Find Yields Further Insight into Causes of Parkinson’s Diseas

In humans, a dearth of the neurotransmitter dopamine has long been known to play a role in Parkinson's disease. It is also known that mutations in a protein called parkin// cause a form of Parkinson's that is inherited.

Now, UCLA scientists, reporting in the Jan. 31 issue of The Journal of Neuroscience, have put the two together. Using a new model of Parkinson's disease they developed in the simple Drosophila (fruit fly), the researchers show for the first time that a mutated form of the human parkin gene inserted into Drosophila specifically results in the death of dopaminergic cells, ultimately resulting in Parkinson's-like motor dysfunction in the fly. Thus, the interaction of mutant parkin with dopamine may be key to understanding the cause of familial Parkinson's disease — Parkinson's that runs in families.

Conventional wisdom has held that parkin is recessive, meaning that two copies of the mutated gene were required in order to see the clinical signs of Parkinson's disease. But the researchers, led by George Jackson, M.D., Ph.D., UCLA associate professor of neurology and senior scientist at the Semel Institute for Neuroscience and Human Behavior at UCLA, wanted to see if they could get the protein to act in a dominant fashion, so they put only one copy of the mutation into their fly model. The result was the death of the neurons that use dopamine, the neurotransmitter long implicated in Parkinson's disease.

"We put the mutant parkin in all different kinds of tissues and in different kinds of neurons, and it was toxic only to the ones that used dopamine," Jackson said. "No one's shown this degree of specificity for dopaminergic neurons."

Having a genetic model of Parkinson's disease (PD) in the fruit fly will allow researchers to run mass testing, or "screens," of genes in order to find the novel pathways — networks of interacting proteins that carry out biological functions — that control survival of those dopaminergic neurons.

"Since a lot of those pathways regulating cell survival and death are conserved by evolution all the way from flies to humans," said Jackson, "if we find those genes in the fly, they may represent new therapeutic targets for PD in humans."

The researchers examined the results not only from a genetic standpoint but from a behavioral standpoint as well. To measure the progression of Parkinson's disease in the fly, they designed a small series of rotating glass cylinders that they christened a "fly rotarod." A healthy fly placed inside the hollow cylinder would simply cling to the wall during the slow 360-degree loop. But flies with Parkinson's disease would fall, depending on the progression of their disease. The researchers used infrared beams to measure when they fell.

The researchers also plan to use their fly model to test a library of some 5,000 drug compounds approved by the Food and Drug Administration to see which ones might stop disease progression. If they find one that works, such a compound, which could serve as a kind of skeleton for other therapeutic drugs, could then be tested in mouse models and eventually in humans.

While non-scientists may have trouble understanding how a simple fruit fly can have implications for humans, Jackson said that, thanks to the biological similarities between species, "the point of what we do is that if we find things, then ultimately, we can examine them in humans."

Besides Jackson, other UCLA investigators included Tzu-Kang Sang, Hui-Yun Chang, George M. Lawless, Anuradha Ratnaparkhi, Lisa Mee, Larry C. Ackerson, Nigel T. Maidment and study co-author David E. Krantz.

Source-Bio-Bio Technology
SI
'"/>




Related medicine news :

1. Operating on a Beating Heart Yields Better Results For Blocked Heart Arteries
2. Fight the Flab Competition Yields Great Results
3. Exercise Combined with Dialysis Yields Better Results
4. Kyphoplasty Yields Good Long-Term Improvement for Spinal Fractures
5. MRI Development Yields Breakthrough in Diagnosis of Liver Fibrosis
6. Cellular Pathway Yields Potential New Weapon in Vaccine Arsenal
7. Researchers Improve Soy Processing by Boosting Protein and Sugar Yields
8. Primitive Yeast Yields Secrets Of Human Cholesterol And Drug Metabolism
9. Tamoxifen Yields Long-term Reduction in Breast Cancer Risk
10. Further support for use of statins in Alzheimer’s disease
11. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... , ... February 13, 2016 , ... ... of Nursing with an in-kind gift of a VeinViewer® Vision vein finder ... they learn how to start an IV and draw blood, combining technology with ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House presents Valentine’s ... Buddha, the biography of Rama - Dr. Frederick Lenz. , According to ... of a Buddhist teacher for teaching and helping others. Valentine’s Day celebrates love ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose ... – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose ... products, garnering increased attention from all stakeholders in the development of new chemical ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Jones Agency, a family owned ... Texas, is launching a cooperative charity drive with the Tarrant Area Food Bank in ... 50,000 individuals and families in need, the Tarrant County Food Bank offers hope and ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... INDIANAPOLIS , Feb. 12, 2016  Eli Lilly and ... High Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent ... in the UK, France , ... instructions to dilute the product only with dextrose solution.  ... of 2015, the UK Court of Appeal held that Lilly,s ...
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... The primary goal of this research is to analyze ... of liquid biopsy. Key information the survey seeks to ... liquid biopsy adoption amidst future users - Predominantly used ... Sample inflow to conduct liquid biopsy tests - Preference ... on. - Correlation analysis of sample type and biomarker ...
Breaking Medicine Technology: